Cargando…
Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method
Abnormal DNA methylation persists throughout carcinogenesis and cancer development. Hence, gene promoter methylation may act as a prognostic tool and provide new potential therapeutic targets for patients with lung adenocarcinoma (LUAD). In this study, to explore prognostic methylation signature, da...
Autores principales: | Cai, Qidong, He, Boxue, Xie, Hui, Zhang, Pengfei, Peng, Xiong, Zhang, Yuqian, Zhao, Zhenyu, Wang, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571836/ https://www.ncbi.nlm.nih.gov/pubmed/32860318 http://dx.doi.org/10.1002/cam4.3343 |
Ejemplares similares
-
Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods
por: Cai, Qidong, et al.
Publicado: (2020) -
A model of twenty-three metabolic-related genes predicting overall survival for lung adenocarcinoma
por: Zhao, Zhenyu, et al.
Publicado: (2020) -
DNA methylome and transcriptome analysis established a model of four differentially methylated positions (DMPs) as a diagnostic marker in esophageal adenocarcinoma early detection
por: Peng, Weilin, et al.
Publicado: (2021) -
Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma
por: Tu, Guangxu, et al.
Publicado: (2021) -
N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non–Small Cell Lung Cancer Prognosis
por: Zhao, Zhenyu, et al.
Publicado: (2021)